NCT03378661: BENDITA BEnznidazole New Doses Improved Treatment and Associations
- State
- State not given
- Phase
- Phase 2
- People
- 210 taking part
- Started
- 30 Nov 2016
- Primary completion
- 28 Jan 2018
- Arms
- BZN 150 mg - 4 wks / E1224 300 mg, BZN 300 mg (weekly) 8 wks / E1224 300 mg
- Results
- None posted
- 30 Nov 2016: Trial started
- 20 Dec 2017: Trial registered